Quasi-VMAT in high-grade glioma radiation therapy

被引:2
|
作者
Fadda, G. [1 ]
Massazza, G. [1 ]
Zucca, S. [1 ]
Durzu, S. [1 ]
Meleddu, G. [1 ]
Possanzini, M. [1 ]
Farace, P. [1 ]
机构
[1] Reg Oncol Hosp, Dept Radiooncol, I-09121 Cagliari, Italy
关键词
Radiotherapy; Organs at risk; Hospital; Radiochemotherapy; Maximum dose; INTENSITY-MODULATED RADIOTHERAPY; CONFORMAL RADIOTHERAPY; PROSTATE-CANCER; PLAN QUALITY; ARC THERAPY; SHOOT IMRT; GLIOBLASTOMA; NUMBER; IMAT;
D O I
10.1007/s00066-012-0296-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To compare a quasi-volumetric modulated arc therapy (qVMAT) with three-dimensional conformal radiation therapy (3D-CRT) and intensity-modulated radiation therapy (IMRT) for the treatment of high-grade gliomas. The qVMAT technique is a fast method of radiation therapy in which multiple equispaced beams analogous to those in rotation therapy are radiated in succession. This study included 12 patients with a planning target volume (PTV) that overlapped at least one organ at risk (OAR). 3D-CRT was planned using 2-3 non-coplanar beams, whereby the field-in-field technique (FIF) was used to divide each field into 1-3 subfields to shield the OAR. The qVMAT strategy was planned with 15 equispaced beams and IMRT was planned using 9 beams with a total of 80 segments. Inverse planning for qVMAT and IMRT was performed by direct machine parameter optimization (DMPO) to deliver a homogenous dose distribution of 60 Gy within the PTV and simultaneously limit the dose received by the OARs to the recommended values. Finally, the effect of introducing a maximum dose objective (max. dose < 54 Gy) for a virtual OAR in the form of a 0.5 cm ring around the PTV was investigated. The qVMAT method gave rise to significantly improved PTV95% and conformity index (CI) values in comparison to 3D-CRT (PTV95% = 90.7 % vs. 82.0 %; CI = 0.79 vs. 0.74, respectively). A further improvement was achieved by IMRT (PTV95% = 94.4 %, CI = 0.78). In qVMAT and IMRT, the addition of a 0.5 cm ring around the PTV produced a significant increase in CI (0.87 and 0.88, respectively), but dosage homogeneity within the PTV was considerably reduced (PTV95% = 88.5 % and 92.3 %, respectively). The time required for qVMAT dose delivery was similar to that required using 3D-CRT. These findings suggest that qVMAT should be preferred to 3D-CRT for the treatment of high-grade gliomas. The qVMAT method could be applied in hospitals, for example, which have limited departmental resources and are not equipped with systems capable of VMAT delivery.
引用
收藏
页码:367 / 371
页数:5
相关论文
共 50 条
  • [21] Recurrent High-Grade Glioma
    Eudocia C. Quant
    Jan Drappatz
    Patrick Y. Wen
    Andrew D. Norden
    Current Treatment Options in Neurology, 2010, 12 : 321 - 333
  • [22] Pseudoprogression in high-grade glioma
    Knudsen-Baas, K. M.
    Moen, G.
    Fluge, O.
    Storstein, A.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 127 : 31 - 37
  • [23] Vincristine in High-grade Glioma
    Aydin, Burca
    Patil, Monali
    Bekele, Nebiyou
    Wolff, Johannes E. A.
    ANTICANCER RESEARCH, 2010, 30 (06) : 2303 - 2310
  • [24] Chemotherapy for high-grade glioma
    Burdett, S
    Stewart, L
    NEUROEPIDEMIOLOGY, 2003, 22 (06) : 366 - 366
  • [25] Recurrent High-Grade Glioma
    Quant, Eudocia C.
    Drappatz, Jan
    Wen, Patrick Y.
    Norden, Andrew D.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2010, 12 (04) : 321 - 333
  • [26] Radioimmunotherapy for high-grade glioma
    De Bonis, Pasquale
    Lofrese, Giorgio
    Anile, Carmelo
    Pompucci, Angelo
    Vigo, Vera
    Mangiola, Annunziato
    IMMUNOTHERAPY, 2013, 5 (06) : 647 - 659
  • [27] Immunotherapy for high-grade glioma
    Dixit, Sanjay
    FUTURE ONCOLOGY, 2014, 10 (06) : 911 - 915
  • [28] VOLUMETRIC MODULATED ARC THERAPY (VMAT) FOR SKULL BASE HIGH GRADE GLIOMA
    Tsutsumi, S.
    Hosono, M.
    Ishii, K.
    Tatsumi, D.
    Nakada, R.
    Ogino, R.
    Kawai, M.
    Takada, Y.
    Tada, T.
    Miki, Y.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S78 - S78
  • [29] Temozolomide in paediatric high-grade glioma: a key for combination therapy?
    A C Verschuur
    J Grill
    A Lelouch-Tubiana
    D Couanet
    C Kalifa
    G Vassal
    British Journal of Cancer, 2004, 91 : 425 - 429
  • [30] High-Grade Glioma: Refined Diagnostics Steering Stratified Therapy
    Uhl, Martin
    Hau, Peter
    CASE REPORTS IN ONCOLOGY, 2013, 6 (02): : 387 - 390